Solórzano SF, Marriaga NB

Language: Spanish
References: 12
Page: 45-46
PDF size: 68.84 Kb.

Text Extraction

No abstract.

REFERENCES

1. Mathis AD, Raines K, Masters NB, Filardo TD, Kim G,Crooke SN, Bankamp B, Rota PA, Sugerman DE. Measles- United States, January 1, 2020-March 28, 2024.MMWR Morb Mortal Wkly Rep. 2024 Apr 11; 73 (14): 295-300.

2. Solórzano-Santos F, Garduño-Espinoza J, Muñoz-HernándezO. Measles outbreak during the COVID-19 pandemicin Mexico. Bol Med Hosp Infant Mex. 2020; 77 (5):282-286.

3. Dirección General de Epidemiologia. Boletín Epidemiológico.Sistema Nacional de Vigilancia Epidemiológica.Número 14 | Volumen 41 | Semana 14 | Del 31 de marzoal 6 de abril del 2024. (https://www.gob.mx/cms/uploads/attachment/file/909238/sem14.pdf)

4. Castiñeiras ACP, Sales AC, Picone CM, Diogo CL, RossiÁD, Galliez RM, Ferreira ODC Jr, Castiñeiras TMPP, LopesMH, Sartori AMC. The decline of measles antibody titersin previously vaccinated adults: a cross-sectional analysis.Rev Inst Med Trop Sao Paulo. 2024 Jan 5; 66: e4.

5. Sheffer R, Bucris E, Amitai Z, Indenbaum V, Lustig Y,Savion M, et al. Measles outbreak associated with apreschool setting among partially vaccinated childrenin the Tel Aviv District, Israel, October 2023. Vaccine.2024; 42 (13): 3153-3156.

6. Pedranti M, Isa MB, Riberi MI, Hernandez G, Alfaro J,Tenaglia M, et al. Measles and Rubella SeroprevalenceAmong Children and Adolescents of Córdoba, Argentina:A Cross-Section Study in the Context of the EliminationProgram. Viral Immunol. 2023; 36 (6): 429-434.

7. Kia M, Nekooei F, Alipour AH, Hashemi SMA, Salimi V,Fattahi MJ, et al. Investigation of the Seroprevalence ofAntimeasles Immunoglobulin G Antibody in Students atShiraz University of Medical Sciences. Viral Immunol.2023; 36 (6): 424-428.

8. Dyda A, Broome A, Rawlinson W, Mahimbo A, Saha A,Kefalas B, et al. Measles, mumps, rubella and varicellaantibodies among international and domestic universitystudents. J Travel Med. 2024; 31 (1): taae004.

9. Han SB, Park SH, Yi Y, Ji SK, Jang SH, Park MH, et al.Measles seroprevalence among healthcare workers inSouth Korea during the post-elimination period. HumVaccin Immunother. 2021; 17 (8): 2517-2521.

10. Cuerda A, González MIT, López Aparicio A, MonfortVinuesa C, López Pedraza MJ, Isidoro B, et al. Seroprevalencefor measles among healthcare workers in Madrid,Spain. J Hosp Infect. 2023; 147: 63-67.

11. Mongua-Rodríguez N, Delgado-Sánchez G, Ferreira-Guerrero E, Ferreyra-Reyes L, Martínez-HernándezM, Cenizales-Quintero S, et al. Cobertura de vacunaciónen niños, niñas y adolescentes en México. Salud PublicaMex. 2023; 65 (supl 1): S23-S33.

12. Mongua-Rodríguez N, Ferreira-Guerrero E, Delgado-Sánchez G, Ferreyra-Reyes L, Martínez-HernándezM, Canizales-Quintero S, et al. Vacunación en adultos yadultos mayores en México. Salud Publica Mex. 2023;65: s146-s152.